Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Nanologix Inc NNLX
(Total Views: 591)
Posted On: 05/12/2017 6:29:07 PM
Post# of 9144
Posted By: mitstevfel
Re: beachlover12 #3623
Beachlover,

If it becomes the Test of Choice/Best Available Technology, then it would be used over time on a large (perhaps all) percentage of the prenatal testing in the USA, 2015 live births were roughly 4,000,000

The selling point for a truly superior test in time and sensitivity could result in a higher cost for the actual test being justifiable over other tests if the end results lowered the amount the insurance companies ultimately paid out due to time savings, the ability to have the test performed in-house, and reduced complications to the patient & neonate due to the benefits of greater sensitivity, rapid results, and reduced dependence upon broad-spectrum antibiotics while awaiting results.

If the N-Assay initially captured only 15% of tests at $150/per test, that could be $90 million in revenue. Not too bad.

Many would argue that the market would not support that number, but you have to look at what the insurance companies pay and then it's obvious it can happen.

Scott













(8)
(2)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site